Management of Select Adverse Events Following Delandistrogene Moxeparvovec Gene Therapy for Patients With Duchenne Muscular Dystrophy.
Zaidman CM, Goedeker NL, Aqul AA, Butterfield RJ, Connolly AM, Crystal RG, Godwin KE, Hor KN, Mathews KD, Proud CM, Kula Smyth E, Veerapandiyan A, Watkins PB, Mendell JR.
Zaidman CM, et al. Among authors: connolly am.
J Neuromuscul Dis. 2024;11(3):687-699. doi: 10.3233/JND-230185.
J Neuromuscul Dis. 2024.
PMID: 38607761
Free PMC article.